\-\ Texto\\:\\ \ \(0\)\
\-\ results\\ of\\ treatment\\ of\\ esophageal\\ cancer\\ are\\ disappointing\\.\\ a\\ large\\ percentage\\ of\\ patients\\ are\\ inoperable\\ at\\ presentation\\.\\ chemotherapy\\ is\\ essentially\\ not\\ effective\\.\\ radiation\\ therapy\\ has\\ been\\ used\\ successfully\\ for\\ palliation\\ and\\ occasionally\\ is\\ curative\\.\\ cancer\\ of\\ the\\ lower\\ one\\-third\\ of\\ the\\ esophagus\\ leads\\ itself\\ most\\ readily\\ to\\ surgical\\ resection\\.\\ prior\\ to\\ tumor\\ resection\\,\\ intra\\-operative\\ evaluation\\ is\\ made\\ for\\ involvement\\ of\\ celiac\\ and\\ periaortic\\ nodes\\ as\\ well\\ as\\ for\\ liver\\ metastasis\\.\\ if\\ these\\ structures\\ are\\ involved\\,\\ no\\ resection\\ is\\ attempted\\.\\ if\\ resection\\ is\\ attempted\\,\\ the\\ extent\\ of\\ the\\ resection\\ may\\ physically\\ prevent\\ re\\-anastamosis\\ necessitating\\ the\\ use\\ of\\ a\\ colon\\ transplant\\.\ \(0\)\
\-\ the\\ pa\\ film\\ shows\\ multiple\\ irregular\\ filling\\ defects\\ involving\\ a\\ large\\ portion\\ of\\ the\\ distal\\ esophagus\\ and\\ the\\ fundus\\ of\\ the\\ stomach\\.\ \(0\)\
\-\ cancer\\ of\\ the\\ gastro\\-esophageal\\ junction\ \(0\)\
\-\ 39\\ y\\.o\\.\\ white\\ male\\ with\\ progressive\\ dysphagia\\,\\ first\\ to\ \(1\)\
\-\ solids\\,\\ then\\ to\\ liquids\ \(1\)\
\-\ pathology\\:\\ cancer\\ of\\ the\\ gastro\\-esophageal\\ junction\\ can\\ be\\ either\\ a\\ primary\\ esophageal\\ cancer\\ invading\\ into\\ the\\ fundus\\ of\\ the\\ stomach\\ or\\ a\\ primary\\ gastric\\ carcinoma\\ originating\\ in\\ the\\ fundus\\ and\\ extending\\ into\\ the\\ lower\\ esophagus\\.\ \(0\)\
\-\ cancer\\ of\\ the\\ esophagus\\ is\\ most\\ commonly\\ squamous\\ cell\\ carcinoma\\.\\ distribution\\ tends\\ to\\ be\\ middle\\>lower\\>upper\\ third\\ of\\ the\\ esophagus\\.\\ males\\ tend\\ to\\ develop\\ it\\ four\\ times\\ as\\ frequently\\ as\\ females\\;\\ however\\,\\ the\\ upper\\ esophagus\\ is\\ involved\\ ten\\ times\\ as\\ frequently\\ in\\ females\\ \\(thought\\ to\\ be\\ due\\ to\\ plummer\\-vinson\\ syndrome\\)\\.\\ the\\ second\\ most\\ common\\ are\\ adenocarcinomas\\ which\\ tend\\ to\\ be\\ in\\ the\\ lower\\ esophagus\\.\\ they\\ very\\ rarely\\ arise\\ from\\ esophageal\\ submucosal\\ glands\\.\\ rather\\,\\ they\\ tend\\ to\\ be\\ an\\ invading\\ gastric\\ adenocarcinoma\\ or\\ an\\ adenocarcinoma\\ arising\\ from\\ the\\ columnar\\ cells\\ of\\ a\\ barrett\\'s\\ esophagus\\.\ \(0\)\
\-\ cancer\\ of\\ the\\ stomach\\ is\\ typically\\ an\\ adenocarcinoma\\.\\ they\\ most\\ commonly\\ \\(50\\%\\)\\ occur\\ in\\ the\\ antrum\\ of\\ the\\ stomach\\ but\\ 10\\%\\ do\\ tend\\ to\\ arise\\ in\\ the\\ fundus\\.\\ the\\ incidence\\ rate\\ is\\ slightly\\ higher\\ for\\ males\\ than\\ females\\.\ \(0\)\
\-\ risk\\ factors\\:\\ the\\ overall\\ incidence\\ rate\\ in\\ the\\ us\\ for\\ esophageal\\ cancer\\ and\\ for\\ gastric\\ cancer\\ are\\ similar\\ \\(10\\/100\\,000\\)\\.\\ the\\ rates\\ tend\\ to\\ be\\ much\\ higher\\ in\\ japan\\ and\\ china\\.\\ aside\\ from\\ barrett\\'s\\ esophagus\\,\\ esophageal\\ cancer\\ is\\ associated\\ with\\ tobacco\\ use\\ \\(smoked\\ and\\ chewed\\)\\,\\ poor\\ dentition\\,\\ and\\ alcohol\\ abuse\\.\\ the\\ etiology\\ of\\ gastric\\ cancer\\ is\\ more\\ mysterious\\ but\\ is\\ thought\\ to\\ be\\ an\ \(0\)\
\-\ environmental\\ or\\ dietary\\ factor\\.\\ in\\ addition\\,\\ achlorhydria\\,\\ pernicious\\ anemia\\,\\ and\\ atrophic\\ gastritis\\ have\\ been\\ shown\\ to\\ be\\ risks\\ for\\ gastric\\ cancer\\.\ \(0\)\
\-\ clinical\\ presentation\\:\\ tumors\\ of\\ the\\ esophago\\-gastric\\ junction\\ most\\ commonly\\ present\\ with\\ dysphagia\\ which\\ may\\ be\\ accompanied\\ with\\ a\\ sensation\\ of\\ substernal\\ fulness\\.\\ there\\ may\\ or\\ may\\ not\\ be\\ pain\\.\\ dysphagia\\ is\\ typically\\ with\\ solid\\ food\\ first\\ but\\ later\\ involve\\ soft\\ food\\ and\\ liquids\\.\\ if\\ the\\ lumen\\ should\\ become\\ obstructed\\,\\ the\\-\\ patient\\ becomes\\ unable\\ to\\ swallow\\ his\\ own\\ saliva\\ leading\\ to\\ constant\\ drooling\\.\\ weight\\ loss\\ commonly\\ occurs\\ in\\ later\\ stages\\ of\\ the\\ disease\\ leading\\ to\\ severe\\ emaciation\\.\ \(0\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ cancer\\:\\ 0\\.3060588976217701\ \(0\)\
\-\ esophagus\\:\\ 0\\.28380595463793484\ \(0\)\
\-\ the\\:\\ 0\\.2597790467769415\ \(0\)\
\-\ esophageal\\:\\ 0\\.22902450291667423\ \(0\)\
\-\ tend\\:\\ 0\\.19556340434467995\ \(0\)\
\-\ gastric\\:\\ 0\\.19352795267515766\ \(0\)\
\-\ of\\:\\ 0\\.1648568939102323\ \(0\)\
\-\ to\\:\\ 0\\.16273798971330397\ \(0\)\
\-\ fundus\\:\\ 0\\.1590596416748929\ \(0\)\
\-\ be\\:\\ 0\\.15533368287890534\ \(0\)\
\-\ is\\:\\ 0\\.1363233660940751\ \(0\)\
\-\ stomach\\:\\ 0\\.1277939593012362\ \(0\)\
\-\ resection\\:\\ 0\\.1227270447939326\ \(0\)\
\-\ females\\:\\ 0\\.11555474965858373\ \(0\)\
\-\ commonly\\:\\ 0\\.11333576209659259\ \(0\)\
\-\ dysphagia\\:\\ 0\\.10375583157600315\ \(0\)\
\-\ most\\:\\ 0\\.09964052146821589\ \(0\)\
\-\ barrett\\:\\ 0\\.09734355178172296\ \(0\)\
\-\ liquids\\:\\ 0\\.09542237026480248\ \(0\)\
\-\ adenocarcinoma\\:\\ 0\\.09389115629720383\ \(0\)\
\-\ junction\\:\\ 0\\.09200356675853281\ \(0\)\
\-\ invading\\:\\ 0\\.08911239848252703\ \(0\)\
\-\ in\\:\\ 0\\.08573134958734079\ \(0\)\
\-\ they\\:\\ 0\\.0820801620796387\ \(0\)\
\-\ for\\:\\ 0\\.08124121480889185\ \(0\)\
\-\ food\\:\\ 0\\.07952982083744645\ \(0\)\
\-\ and\\:\\ 0\\.07912488800698228\ \(0\)\
\-\ males\\:\\ 0\\.07899273448992604\ \(0\)\
\-\ lower\\:\\ 0\\.0782681825327066\ \(0\)\
\-\ attempted\\:\\ 0\\.07726599883456506\ \(0\)\
\-\ may\\:\\ 0\\.0770781471629247\ \(0\)\
\-\ as\\:\\ 0\\.0769154585766011\ \(0\)\
\-\ are\\:\\ 0\\.0726495894301085\ \(0\)\
\-\ arise\\:\\ 0\\.07008776539017261\ \(0\)\
\-\ higher\\:\\ 0\\.06955599812679833\ \(0\)\
\-\ times\\:\\ 0\\.06891960561569897\ \(0\)\
\-\ leading\\:\\ 0\\.06807648039269656\ \(0\)\
\-\ if\\:\\ 0\\.0667451005229942\ \(0\)\
\-\ thought\\:\\ 0\\.06612420362572172\ \(0\)\
\-\ incidence\\:\\ 0\\.0659238212758014\ \(0\)\
\-\ frequently\\:\\ 0\\.06306798991954107\ \(0\)\
\-\ involved\\:\\ 0\\.061406557606994906\ \(0\)\
\-\ mysterious\\:\\ 0\\.061236592610686785\ \(0\)\
\-\ achlorhydria\\:\\ 0\\.061236592610686785\ \(0\)\
\-\ fulness\\:\\ 0\\.061236592610686785\ \(0\)\
\-\ emaciation\\:\\ 0\\.061236592610686785\ \(0\)\
\-\ use\\:\\ 0\\.05859674298202189\ \(0\)\
\-\ an\\:\\ 0\\.058570305844349156\ \(0\)\
\-\ china\\:\\ 0\\.05851483342452302\ \(0\)\
\-\ chewed\\:\\ 0\\.05851483342452302\ \(0\)\
\-\ third\\:\\ 0\\.0583116926092035\ \(0\)\
\-\ rate\\:\\ 0\\.05803256887104391\ \(0\)\
\-\ but\\:\\ 0\\.05680575707362856\ \(0\)\
\-\ disappointing\\:\\ 0\\.05658371454960028\ \(0\)\
\-\ inoperable\\:\\ 0\\.05658371454960028\ \(0\)\
\-\ pernicious\\:\\ 0\\.05658371454960028\ \(0\)\
\-\ environmental\\:\\ 0\\.055085822379651504\ \(0\)\
\-\ later\\:\\ 0\\.054806723632297785\ \(0\)\
\-\ adenocarcinomas\\:\\ 0\\.05386195536343652\ \(0\)\
\-\ typically\\:\\ 0\\.05376223379736807\ \(0\)\
\-\ or\\:\\ 0\\.05328385287060336\ \(0\)\
\-\ columnar\\:\\ 0\\.05282719054524826\ \(0\)\
\-\ presentation\\:\\ 0\\.052718586413996994\ \(0\)\
\-\ physically\\:\\ 0\\.051930836488513786\ \(0\)\
\-\ japan\\:\\ 0\\.051930836488513786\ \(0\)\
\-\ first\\:\\ 0\\.05168122458080585\ \(0\)\
\-\ palliation\\:\\ 0\\.05114019617727276\ \(0\)\
\-\ periaortic\\:\\ 0\\.05114019617727276\ \(0\)\
\-\ saliva\\:\\ 0\\.05114019617727276\ \(0\)\
\-\ necessitating\\:\\ 0\\.049793157189586844\ \(0\)\
\-\ smoked\\:\\ 0\\.049793157189586844\ \(0\)\
\-\ dentition\\:\\ 0\\.04867177589086148\ \(0\)\
\-\ drooling\\:\\ 0\\.04867177589086148\ \(0\)\
\-\ gastritis\\:\\ 0\\.048174312484161756\ \(0\)\
\-\ primary\\:\\ 0\\.04709039706651966\ \(0\)\
\-\ aside\\:\\ 0\\.046487318116186255\ \(0\)\
\-\ percentage\\:\\ 0\\.046124381939385894\ \(0\)\
\-\ solids\\:\\ 0\\.046124381939385894\ \(0\)\
\-\ substernal\\:\\ 0\\.046124381939385894\ \(0\)\
\-\ carcinoma\\:\\ 0\\.045808599881460126\ \(0\)\
\-\ ten\\:\\ 0\\.0457800662574785\ \(0\)\
\-\ from\\:\\ 0\\.04562339151223159\ \(0\)\
\-\ readily\\:\\ 0\\.04514027912850034\ \(0\)\
\-\ atrophic\\:\\ 0\\.04514027912850034\ \(0\)\
\-\ curative\\:\\ 0\\.04484188848847007\ \(0\)\
\-\ dietary\\:\\ 0\\.04484188848847007\ \(0\)\
\-\ 10\\:\\ 0\\.04478195708777959\ \(0\)\
\-\ been\\:\\ 0\\.04461823105608356\ \(0\)\
\-\ tends\\:\\ 0\\.04428217408752972\ \(0\)\
\-\ risks\\:\\ 0\\.04352143442307525\ \(0\)\
\-\ obstructed\\:\\ 0\\.04328587747836903\ \(0\)\
\-\ own\\:\\ 0\\.04328587747836903\ \(0\)\
\-\ antrum\\:\\ 0\\.04262508036634078\ \(0\)\
\-\ submucosal\\:\\ 0\\.04241851994233657\ \(0\)\
\-\ accompanied\\:\\ 0\\.04183444005509975\ \(0\)\
\-\ celiac\\:\\ 0\\.04165051939658511\ \(0\)\
\-\ successfully\\:\\ 0\\.04129713864361121\ \(0\)\
\-\ constant\\:\\ 0\\.04129713864361121\ \(0\)\
\-\ stages\\:\\ 0\\.0409614344883558\ \(0\)\
\-\ upper\\:\\ 0\\.04092486808898828\ \(0\)\
\-\ originating\\:\\ 0\\.040799675236911484\ \(0\)\
\-\ into\\:\\ 0\\.040710302842821136\ \(0\)\
\-\ glands\\:\\ 0\\.040641722440972965\ \(0\)\
\-\ tobacco\\:\\ 0\\.040641722440972965\ \(0\)\
\-\ rates\\:\\ 0\\.03990332118017701\ \(0\)\
\-\ abuse\\:\\ 0\\.03990332118017701\ \(0\)\
\-\ swallow\\:\\ 0\\.03990332118017701\ \(0\)\
\-\ effective\\:\\ 0\\.03911268086893599\ \(0\)\
\-\ itself\\:\\ 0\\.03886855636198875\ \(0\)\
\-\ essentially\\:\\ 0\\.03874974469213563\ \(0\)\
\-\ leads\\:\\ 0\\.03863299941728253\ \(0\)\
\-\ large\\:\\ 0\\.03837197732511404\ \(0\)\
\-\ transplant\\:\\ 0\\.038294473027760366\ \(0\)\
\-\ with\\:\\ 0\\.03748986269660465\ \(0\)\
\-\ occasionally\\:\\ 0\\.03673087706306181\ \(0\)\
\-\ becomes\\:\\ 0\\.036644260582524714\ \(0\)\
\-\ factor\\:\\ 0\\.03591124023111877\ \(0\)\
\-\ alcohol\\:\\ 0\\.03539176800436024\ \(0\)\
\-\ develop\\:\\ 0\\.035250443119090515\ \(0\)\
\-\ overall\\:\\ 0\\.03518088100327774\ \(0\)\
\-\ anemia\\:\\ 0\\.03518088100327774\ \(0\)\
\-\ prevent\\:\\ 0\\.03511203235763672\ \(0\)\
\-\ extent\\:\\ 0\\.035043882695086306\ \(0\)\
\-\ which\\:\\ 0\\.034823136242793845\ \(0\)\
\-\ squamous\\:\\ 0\\.034459802807849486\ \(0\)\
\-\ rarely\\:\\ 0\\.034156009604867955\ \(0\)\
\-\ lumen\\:\\ 0\\.034096866631049126\ \(0\)\
\-\ become\\:\\ 0\\.033980121356196026\ \(0\)\
\-\ rather\\:\\ 0\\.03392250139636095\ \(0\)\
\-\ involve\\:\\ 0\\.03369684370740039\ \(0\)\
\-\ much\\:\\ 0\\.03316381109357851\ \(0\)\
\-\ unable\\:\\ 0\\.03316381109357851\ \(0\)\
\-\ defects\\:\\ 0\\.03301181929981184\ \(0\)\
\-\ sensation\\:\\ 0\\.0328143731801333\ \(0\)\
\-\ nodes\\:\\ 0\\.032528683932926745\ \(0\)\
\-\ distribution\\:\\ 0\\.03248222918624725\ \(0\)\
\-\ factors\\:\\ 0\\.03239027317147295\ \(0\)\
\-\ poor\\:\\ 0\\.032299559843628596\ \(0\)\
\-\ 39\\:\\ 0\\.03182143207421899\ \(0\)\
\-\ do\\:\\ 0\\.03173804362168572\ \(0\)\
\-\ either\\:\\ 0\\.03165567836618279\ \(0\)\
\-\ four\\:\\ 0\\.03103079176297796\ \(0\)\
\-\ addition\\:\\ 0\\.030993602282234006\ \(0\)\
\-\ etiology\\:\\ 0\\.03084687110446332\ \(0\)\
\-\ us\\:\\ 0\\.030459154296550217\ \(0\)\
\-\ arising\\:\\ 0\\.03042499298056026\ \(0\)\
\-\ not\\:\\ 0\\.0302332197640585\ \(0\)\
\-\ occurs\\:\\ 0\\.03019061112279001\ \(0\)\
\-\ pathology\\:\\ 0\\.03006026364651547\ \(0\)\
\-\ slightly\\:\\ 0\\.029869368770121956\ \(0\)\
\-\ results\\:\\ 0\\.029838074148851177\ \(0\)\
\-\ shown\\:\\ 0\\.02968375277529205\ \(0\)\
\-\ filling\\:\\ 0\\.029653309711301475\ \(0\)\
\-\ irregular\\:\\ 0\\.02956280023981574\ \(0\)\
\-\ made\\:\\ 0\\.029532899593029183\ \(0\)\
\-\ cells\\:\\ 0\\.029503131543781456\ \(0\)\
\-\ pa\\:\\ 0\\.029385362135261783\ \(0\)\
\-\ solid\\:\\ 0\\.02935623981581154\ \(0\)\
\-\ progressive\\:\\ 0\\.02932724329510953\ \(0\)\
\-\ similar\\:\\ 0\\.029184110279430322\ \(0\)\
\-\ colon\\:\\ 0\\.02915584630460175\ \(0\)\
\-\ structures\\:\\ 0\\.02877215992857472\ \(0\)\
\-\ used\\:\\ 0\\.028666446183081274\ \(0\)\
\-\ second\\:\\ 0\\.028666446183081274\ \(0\)\
\-\ film\\:\\ 0\\.0286142071326362\ \(0\)\
\-\ occur\\:\\ 0\\.028161495119046795\ \(0\)\
\-\ tumors\\:\\ 0\\.028161495119046795\ \(0\)\
\-\ metastasis\\:\\ 0\\.02806490806986696\ \(0\)\
\-\ involvement\\:\\ 0\\.02771460159407279\ \(0\)\
\-\ very\\:\\ 0\\.027468851936626244\ \(0\)\
\-\ portion\\:\\ 0\\.027381672995650214\ \(0\)\
\-\ middle\\:\\ 0\\.027381672995650214\ \(0\)\
\-\ risk\\:\\ 0\\.027360054026546232\ \(0\)\
\-\ chemotherapy\\:\\ 0\\.02718956399618259\ \(0\)\
\-\ then\\:\\ 0\\.02710591575982589\ \(0\)\
\-\ involving\\:\\ 0\\.02682109249779819\ \(0\)\
\-\ 50\\:\\ 0\\.02674188586667205\ \(0\)\
\-\ weight\\:\\ 0\\.026702630292198187\ \(0\)\
\-\ liver\\:\\ 0\\.026415310367440898\ \(0\)\
\-\ extending\\:\\ 0\\.02596219074635193\ \(0\)\
\-\ radiation\\:\\ 0\\.02537519039611294\ \(0\)\
\-\ white\\:\\ 0\\.02526370790796971\ \(0\)\
\-\ should\\:\\ 0\\.024985261736177797\ \(0\)\
\-\ clinical\\:\\ 0\\.02426741129880903\ \(0\)\
\-\ severe\\:\\ 0\\.02424023440296452\ \(0\)\
\-\ evaluation\\:\\ 0\\.02335236131274617\ \(0\)\
\-\ loss\\:\\ 0\\.023328641556247184\ \(0\)\
\-\ his\\:\\ 0\\.02322292781075374\ \(0\)\
\-\ syndrome\\:\\ 0\\.02308451704929995\ \(0\)\
\-\ however\\:\\ 0\\.022664145791800382\ \(0\)\
\-\ shows\\:\\ 0\\.02247385223977203\ \(0\)\
\-\ distal\\:\\ 0\\.022248366840998072\ \(0\)\
\-\ due\\:\\ 0\\.022010724888011514\ \(0\)\
\-\ therapy\\:\\ 0\\.022001003403177576\ \(0\)\
\-\ cell\\:\\ 0\\.02190455513327197\ \(0\)\
\-\ common\\:\\ 0\\.021715718936874125\ \(0\)\
\-\ than\\:\\ 0\\.021706415145911994\ \(0\)\
\-\ these\\:\\ 0\\.02162325626141296\ \(0\)\
\-\ patients\\:\\ 0\\.021541114982290315\ \(0\)\
\-\ prior\\:\\ 0\\.021424213309349946\ \(0\)\
\-\ more\\:\\ 0\\.021026179885886735\ \(0\)\
\-\ soft\\:\\ 0\\.020385629040643508\ \(0\)\
\-\ associated\\:\\ 0\\.020182540754566297\ \(0\)\
\-\ can\\:\\ 0\\.02009421468937598\ \(0\)\
\-\ tumor\\:\\ 0\\.020028724568898624\ \(0\)\
\-\ present\\:\\ 0\\.019648659819128632\ \(0\)\
\-\ it\\:\\ 0\\.01960093103630108\ \(0\)\
\-\ have\\:\\ 0\\.01912875083879276\ \(0\)\
\-\ multiple\\:\\ 0\\.018729251300907395\ \(0\)\
\-\ surgical\\:\\ 0\\.018610963057629028\ \(0\)\
\-\ well\\:\\ 0\\.018540977880473503\ \(0\)\
\-\ treatment\\:\\ 0\\.0182403173541921\ \(0\)\
\-\ has\\:\\ 0\\.017490483758919078\ \(0\)\
\-\ male\\:\\ 0\\.01704889002053149\ \(0\)\
\-\ disease\\:\\ 0\\.01607345023822639\ \(0\)\
\-\ there\\:\\ 0\\.015236105843609139\ \(0\)\
\-\ at\\:\\ 0\\.014463219269521035\ \(0\)\
\-\ pain\\:\\ 0\\.013702140999598284\ \(0\)\
\-\ patient\\:\\ 0\\.01245433277898929\ \(0\)\
\-\ no\\:\\ 0\\.012451990191596964\ \(0\)\
